Persistent COVID-19 parosmia and olfactory loss post olfactory training: randomized clinical trial comparing central and peripheral-acting therapeutics
European Archives of Oto-Rhino-Laryngology(2024)
Abstract
Although COVID-19 anosmia is often transient, patients with persistent olfactory dysfunction (pOD) can experience refractory parosmia and diminished smell. This study evaluated four putative therapies for parosmia in patients with chronic COVID-19 olfactory impairment. After screening nasal endoscopy, 85 patients (49 female, 58
MoreTranslated text
Key words
Anosmia,Parosmia,Coronavirus long-COVID,Palmitoylethanolamide,Alpha lipoic acid
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined